CODEN (USA): IJPSPP Lysozyme hydrochloride Inhibits Cytokines in Epithelial Cells with Respiratory Syncytial Virus Infection: a Brief Report

Lysozyme hydrochloride, derived from Hen Egg Lysozyme, is one of classical anti-airway inflammatory drugs. It has been widely administered in Japan, but its molecular potential is unknown. To confirm this classical drug as anti-inflammatory agent, pro-inflammatory cytokines in Epithelial Cells infected by RSV with lysozyme hydrochloride were measured. Lysozyme hydrochloride suppressed the production of IL-6, IL-1β, G-CSF although IL-8 and IFN-γ was not changed. Lysozyme hydrochloride inhibits pro-inflammatory cytokines in Epithelial cells infected with Respiratory Syncytial Virus, and may affect to airway inflammation.

[1]  J. Hurst,et al.  COPD exacerbations: causes, prevention, and treatment. , 2013, Immunology and allergy clinics of North America.

[2]  R. Nagatomi,et al.  l-carbocisteine inhibits respiratory syncytial virus infection in human tracheal epithelial cells , 2012, Respiratory Physiology & Neurobiology.

[3]  E. Walsh,et al.  Respiratory Syncytial Virus Infection in Adults , 2011, Seminars in respiratory and critical care medicine.

[4]  R. Nagatomi,et al.  Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells. , 2009, Antiviral research.

[5]  H. Shirasawa,et al.  Tiotropium Bromide Attenuates Respiratory Syncytial Virus Replication in Epithelial Cells , 2008, Respiration.

[6]  J. D. Beckham,et al.  Respiratory viral infections in patients with chronic, obstructive pulmonary disease , 2004, Journal of Infection.

[7]  W. König,et al.  Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. , 1995, Immunology.

[8]  M. Perkins,et al.  Primary respiratory syncytial virus infection in mice , 1988, Journal of medical virology.

[9]  C. Bauer,et al.  The influence of cigarette smoking on viral infections: translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically. , 2013, Chest.

[10]  L. Anderson,et al.  Clinical and epidemiologic features of respiratory syncytial virus. , 2013, Current topics in microbiology and immunology.